IP Library Patent Application 12424357
Patent Application
App. No. 12/424,357

SUBMUCOSAL FIBROID ABLATION FOR THE TREATMENT OF MENORRHAGIA

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/424,357
Abstract

Submucosal fibroids are selectively treated by introducing a visualization and ablation instrument into a patient's uterus. Many or all of the fibroids are visualized, and the submucosal fibroids are identified. The identified submucosal fibroids are then selectively targeted, typically using a needle on the visualization and ablation instrument. In this way, the patients can be treated for menorrhagia without prolonging the time to treat intramural and subserosal fibroids which typically aren't responsible for menorrhagia.

Claims (31)

1 . A method for treating menorrhagia, said method comprising:

providing a visualization and ablation instrument comprising a shaft having a distal end, an imaging transducer near the distal end of the shaft, and an energy delivery element near the distal end of the shaft;

advancing the distal end of the shaft into a uterus;

visualizing fibroids with the imaging transducer while the distal end remains in the uterus;

distinguishing submucosal fibroids from all other fibroids;

selectively delivering energy from the energy delivery element to the submucosal fibroid(s).

2 . A method as in claim 1 , wherein selectively delivering energy comprises targeting only the submucosal fibroid(s).

3 . A method as in claim 1 , wherein selectively delivering energy comprises delivering energy only to the submucosal fibroid(s).

4 . A method as in claim 1 , wherein advancing comprises advancing the distal end through a vagina and cervical os into the uterus.

5 . A method as in claim 1 , further comprising manipulating a proximal end of the shaft to position the imaging transducer to visualize different wall regions of the uterus.

6 . A method as in claim 1 , wherein visualizing comprises ultrasonic imaging with an ultrasonic transducer.

7 . A method as in claim 1 , wherein distinguishing further comprises determining which submucosal fibroids cause bleeding.

8 . A method as in claim 1 , wherein selectively delivering energy comprises advancing a needle from the shaft into the submucosal fibroid(s) and delivering radiofrequency energy via the needle to the submucosal fibroid(s).

9 . A method for treating menorrhagia in a patient, said method comprising:

providing a visualization means including an imaging transducer for visualizing fibroids;

providing an energy delivery element;

employing said visualization means for visualizing uterine fibroids;

visualizing fibroids with the imaging transducer;

distinguishing submucosal fibroids from all other fibroids; and

selectively targeting the submucosal fibroid(s) by delivering energy from the energy delivery element to the submucosal fibroid(s).

10 . A method as in claim 9 , further comprising inserting said energy delivery element into a uterus of the patient.

11 . A method as in claim 10 , further comprising inserting said visualization means into the uterus.

12 . A method as in claim 9 , wherein said energy delivery element comprises a mechanical element.

13 . A method as in claim 9 , wherein said energy delivery element comprises an ablative element using ablative energy.

14 . A method as in claim 9 , wherein said energy delivery element and said visualization means are disposed at the distal end of a common shaft.

15 . A method as in claim 14 , further comprising advancing the distal end of the shaft into a uterus of the patient.

16 . A method as in claim 10 , wherein said imaging transducer is external of the uterus.

17 . A method as in claim 9 , wherein said energy from said delivery element is delivered to the fibroid from a position external of a uterus of the patient.

18 . A method as in claim 17 , wherein said imaging transducer is external of the uterus.

19 . A method as in claim 9 , further comprising inserting said visualization means into the uterus.

20 . A method as in claim 19 , wherein said energy from said delivery element is delivered to the fibroid from a position external of a uterus of the patient.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Oct 18, 2010
From: LIGHTHOUSE CAPITAL PARTNERS VI, L.P.
To: GYNESONICS, INC.
Reel/Frame 025151/0672 →
SECURITY AGREEMENT Recorded Nov 19, 2009
From: GYNESONICS, INC.
To: LIGHTHOUSE CAPITAL PARTNERS VI, L.P.
Reel/Frame 023547/0205 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 29, 2009
From: GROSSMAN, JESSICA; BELLEZA, TEODORO; GERBI, CRAIG; MUNROW, MICHAEL; BAJOR, JORDAN
To: GYNESONICS, INC.
Reel/Frame 023031/0894 →